Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment

Gretel Sanabria-Diaz1, Jean-Francois Demonet2, Borja Rodriguez-Herreros3

  • 1LREN, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV), Rue du Bugnon 46, Mont Paisible 16, Lausanne, Vaud 1011, Switzerland; Faculty of Biology and Medicine, University of Lausanne (UNIL), Rue du Bugnon 21, Lausanne CH-1011, Switzerland.

Neuroimage. Clinical
|September 1, 2021
PubMed

Insights

Apolipoprotein E4 (ApoE4) and disease progression impact gray matter networks in Mild Cognitive Impairment (MCI). Single-Subject Gray Matter Networks (SSGMNets) can identify MCI patients at high risk for Alzheimer's disease progression.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Genetics

Background:

  • Gray matter network disruptions are linked to Mild Cognitive Impairment (MCI) and Alzheimer's disease (AD) progression.
  • Apolipoprotein E isoform E4 (ApoE4) is a significant genetic risk factor for late-onset AD, but its specific impact on MCI gray matter networks is unclear.

Purpose of the Study:

  • To investigate the individual-level impact of ApoE4 and disease progression on Single-Subject Gray Matter Networks (SSGMNets) in MCI patients.
  • To determine if SSGMNets' topological properties and their changes over time correlate with ApoE4 status and conversion to AD.
  • To explore the relationship between SSGMNets attributes and cognitive/biomarker measures in MCI.

Main Methods:

  • Utilized graph theory to analyze SSGMNets from structural MRIs of 200 MCI patients from the ADNI database.
  • Classified patients into converters and non-converters, and further into ApoE4 carriers and non-carriers.
  • Assessed network topological measures at baseline and their rate of change (RoC) between baseline and conversion.

Main Results:

  • ApoE4 status and disease progression independently modulated global topological network properties, but not their rate of change.
  • MCI converters exhibited a reduced clustering index in brain regions affected by AD neurodegeneration.
  • SSGMNets' topological organization demonstrated predictive capability for cognitive and memory decline.

Conclusions:

  • SSGMNets are sensitive to the influence of ApoE4 and disease progression in MCI.
  • Altered network topology in MCI converters is associated with neurodegenerative patterns seen in AD.
  • SSGMNets hold potential for identifying MCI ApoE4 carriers at elevated risk for AD progression.